Showing results (291-300 of 426) with videos related to

Sort By:
Pageof 43
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 19, 2018
Influence of HIV Infection on the Natural History of Hepatocellular Carcinoma: Results From a Global Multicohort StudyDavid J Pinato, Elias Allara, Ting-Yi Chen, et al.
JAMA Oncology|November 17, 2022
Association of Machine Learning-Based Assessment of Tumor-Infiltrating Lymphocytes on Standard Histologic Images With Outcomes of Immunotherapy in Patients With NSCLCMehrdad Rakaee, Elio Adib, Biagio Ricciuti, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|February 27, 2025
The 2024 ILTS-ILCA consensus recommendations for liver transplantation for HCC and intrahepatic cholangiocarcinomaSudha Kodali, Laura Kulik, Antonio D'Allessio, et al.
Clinical Genitourinary Cancer|December 8, 2022
Treatment Rechallenge With Immune Checkpoint Inhibitors in Advanced Urothelial CarcinomaDimitrios Makrakis, Dimitra Rafailia Bakaloudi, Rafee Talukder, et al.
Liver Cancer|June 18, 2026
The 2024 International Liver Transplant Society and International Liver Cancer Association Consensus Recommendations for Liver Transplantation for Liver CancerSudha Kodali, Laura Kulik, Antonio D'Alessio, et al.
The Lancet. Oncology|October 22, 2024
Pathological response following neoadjuvant immune checkpoint inhibitors in patients with hepatocellular carcinoma: a cross-trial, patient-level analysisAntonio D'Alessio, Bernardo Stefanini, Julia Blanter, et al.
Journal for Immunotherapy of Cancer|June 16, 2022
Integrated use of PD-1 inhibition and transarterial chemoembolization for hepatocellular carcinoma: evaluation of safety and efficacy in a retrospective, propensity score-matched studyBrett Marinelli, Edward Kim, Antonio D'Alessio, et al.
Cancers|October 28, 2023
Characterization of Age-Associated, Neutrophil-to-Lymphocyte Ratio (NLR) and Systemic Immune-Inflammatory Index (SII) as Biomarkers of Inflammation in Geriatric Patients with Cancer Treated with Immune Checkpoint Inhibitors: Impact on Efficacy and SurvivalKhalil Choucair, Caroline Nebhan, Alessio Cortellini, et al.
Therapeutic Advances in Medical Oncology|May 17, 2021
Antacid exposure and immunotherapy outcomes among patients with advanced hepatocellular carcinomaTomi Jun, Umut Ozbek, Sirish Dharmapuri, et al.
Cancers|July 16, 2020
Immunotherapy in Hepatocellular Cancer Patients with Mild to Severe Liver Dysfunction: Adjunctive Role of the ALBI GradeDavid J Pinato, Takahiro Kaneko, Anwaar Saeed, et al.
Pageof 43